Cargando…

Contraceptive effectiveness, pharmacokinetics, and safety of Sayana® Press when injected every four months: a multicenter phase 3 trial

BACKGROUND: Sayana Press® is a 3-monthly contraceptive injection approved by regulatory agencies in more than 40 countries worldwide. Existing effectiveness and pharmacokinetics (PK) data suggest that high contraceptive efficacy may be maintained if the reinjection interval of Sayana Press is extend...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deese, Jennifer, Brache, Vivian, Bahamondes, Luis, Salinas, Abril, Jorge, Aidelis, Veiga, Nelio, Fuchs, Rachael, Miller, Ashley, Taylor, Doug, Halpern, Vera, Dorflinger, Laneta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804165/ https://www.ncbi.nlm.nih.gov/pubmed/35128365 http://dx.doi.org/10.1016/j.eclinm.2022.101273

Ejemplares similares

Return to ovulation after Sayana Press is injected every 4 months for one year: Empirical and pharmacokinetic/pharmacodynamic modeling results()
por: Taylor, Douglas J., et al.
Publicado: (2022)

Suppression of ovulation and pharmacokinetics following subcutaneous administration of various doses of Depo-Provera®: a randomized trial
por: Halpern, Vera, et al.
Publicado: (2021)

Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate
por: Taylor, Douglas J., et al.
Publicado: (2022)

Levonorgestrel release rates measured through analysis of two-rod contraceptive explants
por: Fuchs, Rachael, et al.
Publicado: (2020)

A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation()
por: Halpern, Vera, et al.
Publicado: (2023)

Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera
por: Halpern, Vera, et al.
Publicado: (2021)

Pilot Research as Advocacy: The Case of Sayana Press in Kinshasa, Democratic Republic of the Congo
por: Binanga, Arsene, et al.
Publicado: (2016)

Acceptability of the community-level provision of Sayana® Press by medical and nursing students in Kinshasa, Democratic Republic of the Congo
por: Bertrand, Jane T., et al.
Publicado: (2017)

Contraception in the Era of COVID-19
por: Nanda, Kavita, et al.
Publicado: (2020)

Randomized trial to evaluate contraceptive efficacy, safety and acceptability of a two-rod contraceptive implant over 4 years in the Dominican Republic()
por: Steiner, M.J., et al.
Publicado: (2019)

Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women()()
por: Heffron, Renee, et al.
Publicado: (2019)

Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant
por: Ali, Moazzam, et al.
Publicado: (2016)

Knowledge, Attitude, and Practices Related to the SARS-CoV-2 Pandemic among Women Seeking Contraceptive Methods
por: Garcia, Elaine Aparecida Lopes, et al.
Publicado: (2022)

Potential biomarkers to predict return to fertility after discontinuation of female contraceptives—looking to the future
por: Cordova-Gomez, Amanda, et al.
Publicado: (2023)

IUD self-removal as self-care: Research is needed in low and middle-income countries
por: Cartwright, Alice F., et al.
Publicado: (2022)

Planning for Outcomes (P(4)O) Modeling Tool: Estimating the Impact of Changing the Proportion of Injectable Progestins in the Contraceptive Method Mix
por: Lebetkin, Elena, et al.
Publicado: (2019)

New and emerging contraceptives: a state-of-the-art review
por: Bahamondes, Luis, et al.
Publicado: (2014)

WHO Tiered-Effectiveness Counseling Is Rights-Based Family Planning
por: Stanback, John, et al.
Publicado: (2015)

Contraceptive use and the risk of sexually transmitted infection: systematic review and current perspectives
por: Deese, Jennifer, et al.
Publicado: (2018)

Contraceptive sales in the setting of the Zika virus epidemic
por: Bahamondes, Luis, et al.
Publicado: (2017)

New approaches for developing biomarkers of hormonal contraceptive use
por: Sachdeva, Rakhee, et al.
Publicado: (2023)

Management of pain associated with the insertion of intrauterine contraceptives
por: Gemzell-Danielsson, K., et al.
Publicado: (2013)

‘Hard-pressed on every side’: Christian women’s experiences of intimate partner violence in two provinces of South Africa
por: Nevhutanda, Tshilidzi R., et al.
Publicado: (2023)

Cohort study to evaluate efficacy, safety and acceptability of a two-rod contraceptive implant during third, fourth and fifth year of product use in China
por: Che, Y, et al.
Publicado: (2019)

Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial()()
por: Nanda, Kavita, et al.
Publicado: (2016)

Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials
por: Archer, David F, et al.
Publicado: (2019)

Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception did not influence early discontinuation
por: Bahamondes, Luis
Publicado: (2021)

Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives
por: Bahamondes, Luis, et al.
Publicado: (2014)

Knowledge and attitudes of Latin American obstetricians and gynecologists regarding intrauterine contraceptives
por: Bahamondes, Luis, et al.
Publicado: (2015)

A Multi-Compartment, Single and Multiple Dose Pharmacokinetic Study of the Vaginal Candidate Microbicide 1% Tenofovir Gel
por: Schwartz, Jill L., et al.
Publicado: (2011)

Vedolizumab Efficacy, Safety, and Pharmacokinetics With Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients With Crohn’s Disease or Ulcerative Colitis
por: Vermeire, Séverine, et al.
Publicado: (2020)

“Every method seems to have its problems”- Perspectives on side effects of hormonal contraceptives in Morogoro Region, Tanzania
por: Chebet, Joy J., et al.
Publicado: (2015)

Sexual Function and Quality of Life in a Cohort of Brazilian Users of Two Kind of Intrauterine Contraceptives
por: Ferreira, Jéssica Mayra, et al.
Publicado: (2019)

Use of hormonal contraceptives to control menstrual bleeding: attitudes and practice of Brazilian gynecologists
por: Makuch, María Y, et al.
Publicado: (2013)

Effect of Prucalopride on the Pharmacokinetics of Oral Contraceptives in Healthy Women
por: Van de Velde, Vera, et al.
Publicado: (2013)

Every-Day Lessons from Every-Day Cases
por: Reed, Charles A. L.
Publicado: (1908)

Knowledge and attitudes of Latin American gynecologists regarding unplanned pregnancy and use of combined oral contraceptives
por: Bahamondes, Luis, et al.
Publicado: (2015)

Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks
por: Kerbusch, T, et al.
Publicado: (2004)

Interventions for the prevention of pain associated with the placement of intrauterine contraceptives: An updated review
por: Gemzell‐Danielsson, Kristina, et al.
Publicado: (2019)

The use of long-acting reversible contraceptives in Latin America and the Caribbean: current landscape and recommendations
por: Bahamondes, Luis, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m2kd8oitj11muf641moba8k645